iConnect

Results

Therapies’ Development

More in this section
sdg3

Therapies' Development research directly aligns with the objectives of SDG 3 by focusing on the development of new therapies, treatments, and interventions to prevent, diagnose, and treat diseases. Improved healthcare outcomes, reduced mortality rates, and better quality of life for individuals

health and wellbeing

Description of Subtheme:

Therapies' Development includes two vital areas. The first focuses on optimizing pharmacotherapeutic plans for individuals afflicted with chronic disorders. This research seeks to tailor treatment regimens to the specific needs of patients, enhancing the effectiveness of medications and improving their overall well-being. In parallel, scientists in this subtheme are exploring the development of novel drug combinations aimed at reducing bacterial virulence factors. By tackling this aspect of infectious diseases, the goal is to create innovative treatments that can mitigate the harm caused by virulent bacteria, potentially revolutionizing the field of antibiotic therapy.

Research Action Plan:

Optimizing pharmacotherapeutic plan for patients with chronic disorders

Prominent Research:

Kawthar K. Ablaa, Soumaya M. Hijazi, Mohammed M. Mehanna, (2023). “Augmented efficiency of azithromycin for MRSA ocular infections management: limonene-based nanostructured-lipid carriers in-situ gel approach”. Journal of Drug Delivery Science and Technology, 87 104764. https://doi.org/10.1016/j.jddst.2023